PLoS ONE (Jan 2022)

What matters most to patients with severe aortic stenosis when choosing treatment? Framing the conversation for shared decision making.

  • Nananda F Col,
  • Diana Otero,
  • Brian R Lindman,
  • Aaron Horne,
  • Melissa M Levack,
  • Long Ngo,
  • Kimberly Goodloe,
  • Susan Strong,
  • Elvin Kaplan,
  • Melissa Beaudry,
  • Megan Coylewright

DOI
https://doi.org/10.1371/journal.pone.0270209
Journal volume & issue
Vol. 17, no. 8
p. e0270209

Abstract

Read online

BackgroundGuidelines recommend including the patient's values and preferences when choosing treatment for severe aortic stenosis (sAS). However, little is known about what matters most to patients as they develop treatment preferences. Our objective was to identify, prioritize, and organize patient-reported goals and features of treatment for sAS.MethodsThis multi-center mixed-methods study conducted structured focus groups using the nominal group technique to identify patients' most important treatment goals and features. Patients separately rated and grouped those items using card sorting techniques. Multidimensional scaling and hierarchical cluster analyses generated a cognitive map and clusters.Results51 adults with sAS and 3 caregivers with experience choosing treatment (age 36-92 years) were included. Participants were referred from multiple health centers across the U.S. and online. Eight nominal group meetings generated 32 unique treatment goals and 46 treatment features, which were grouped into 10 clusters of goals and 11 clusters of features. The most important clusters were: 1) trust in the healthcare team, 2) having good information about options, and 3) long-term outlook. Other clusters addressed the need for and urgency of treatment, being independent and active, overall health, quality of life, family and friends, recovery, homecare, and the process of decision-making.ConclusionsThese patient-reported items addressed the impact of the treatment decision on the lives of patients and their families from the time of decision-making through recovery, homecare, and beyond. Many attributes had not been previously reported for sAS. The goals and features that patients' value, and the relative importance that they attach to them, differ from those reported in clinical trials and vary substantially from one individual to another. These findings are being used to design a shared decision-making tool to help patients and their clinicians choose a treatment that aligns with the patients' priorities.Trial registrationClinicalTrials.gov, Trial ID: NCT04755426, Trial URL https://clinicaltrials.gov/ct2/show/NCT04755426.